What exactly is it?
According to the South China Morning Post, the “cadaver skin jab” is the Chinese social media nickname for Elravie Re2O, a skin booster developed by South Korean biotech firm L&C Bio, distributed by Humedix and launched in November 2024.
The distributor says the product contains human acellular dermal matrix, processed from the tissue of deceased donors obtained through tissue banks in the United States.
The company claims it improves skin by directly supplying structural proteins such as collagen and elastin, calling this “structural replenishment” for ageing skin, unlike traditional boosters that provide only temporary stimulation.
Why is it under scrutiny?
Over the past week, Hong Kong's Department of Health seized 20 vials of Elravie Re2O during inspections of four beauty premises in Mong Kok and Tsim Sha Tsui. It is not yet known whether any customers received the injections in the city.















